MDXG
Income statement / Annual
Last year (2025), Mimedx Group Inc's total revenue was $418.63 M,
an increase of 19.99% from the previous year.
In 2025, Mimedx Group Inc's net income was $48.58 M.
See Mimedx Group Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$418.63 M |
$348.88 M |
$321.48 M |
$267.84 M |
$242.02 M |
$248.23 M |
$299.26 M |
$359.11 M |
$321.14 M |
$245.02 M |
| Cost of Revenue |
$73.01 M
|
$60.07 M
|
$54.63 M
|
$48.32 M
|
$39.63 M
|
$39.33 M
|
$43.08 M
|
$36.39 M
|
$35.22 M
|
$32.41 M
|
| Gross Profit |
$345.62 M
|
$288.81 M
|
$266.84 M
|
$219.53 M
|
$202.39 M
|
$208.90 M
|
$256.17 M
|
$322.73 M
|
$285.92 M
|
$212.61 M
|
| Gross Profit Ratio |
0.83
|
0.83
|
0.83
|
0.82
|
0.84
|
0.84
|
0.86
|
0.9
|
0.89
|
0.87
|
| Research and Development Expenses |
$15.10 M
|
$12.34 M
|
$12.67 M
|
$12.70 M
|
$9.93 M
|
$11.72 M
|
$11.14 M
|
$15.77 M
|
$17.90 M
|
$14.34 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$266.19 M
|
$216.39 M
|
$216.30 M
|
$220.85 M
|
$194.85 M
|
$240.49 M
|
$264.71 M
|
$295.25 M
|
$219.53 M
|
$172.32 M
|
| Other Expenses |
$0.00
|
$1.21 M
|
$762.00 K
|
$701.00 K
|
$4.66 M
|
$2.10 M
|
$1.49 M
|
$15.63 M
|
$2.27 M
|
$4.71 M
|
| Operating Expenses |
$281.29 M
|
$229.94 M
|
$229.73 M
|
$234.25 M
|
$209.44 M
|
$254.30 M
|
$277.33 M
|
$326.65 M
|
$239.70 M
|
$191.38 M
|
| Cost And Expenses |
$354.74 M
|
$290.01 M
|
$284.36 M
|
$282.57 M
|
$249.07 M
|
$293.63 M
|
$320.42 M
|
$363.04 M
|
$274.92 M
|
$220.83 M
|
| Interest Income |
$4.72 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$527.00 K
|
$0.00
|
$0.00
|
| Interest Expense |
$1.78 M
|
$1.01 M
|
$6.46 M
|
$5.02 M
|
$4.98 M
|
$7.94 M
|
$4.71 M
|
$0.00
|
$87.00 K
|
$339.00 K
|
| Depreciation & Amortization |
$14.88 M
|
$6.04 M
|
$3.43 M
|
$4.05 M
|
$5.18 M
|
$6.86 M
|
$7.59 M
|
$6.92 M
|
$5.77 M
|
$5.47 M
|
| EBITDA |
$82.93 M |
$65.35 M |
$40.52 M |
-$10.69 M |
-$1.89 M |
-$37.52 M |
-$13.13 M |
$17.59 M |
$52.58 M |
$8.93 M |
| EBITDA Ratio |
0.2
|
0.19
|
0.13
|
-0.04
|
-0.01
|
-0.15
|
-0.04
|
0.05
|
0.16
|
0.04
|
| Operating Income Ratio |
0.15
|
0.17
|
0.12
|
-0.05
|
-0.03
|
-0.18
|
-0.07
|
-0.01
|
0.14
|
0
|
| Total Other Income/Expenses Net |
$2.38 M
|
-$1.57 M
|
-$6.48 M
|
-$5.02 M
|
-$5.00 M
|
-$16.15 M
|
-$4.43 M
|
$527.00 K
|
-$1.14 M
|
-$339.00 K
|
| Income Before Tax |
$66.26 M
|
$57.29 M
|
$30.63 M
|
-$19.75 M
|
-$12.05 M
|
-$61.54 M
|
-$25.59 M
|
-$3.40 M
|
$45.09 M
|
$545.00 K
|
| Income Before Tax Ratio |
0.16
|
0.16
|
0.1
|
-0.07
|
-0.05
|
-0.25
|
-0.09
|
-0.01
|
0.14
|
0
|
| Income Tax Expense |
$17.68 M
|
$15.30 M
|
-$36.81 M
|
$206.00 K
|
$247.00 K
|
-$12.26 M
|
-$5.00 K
|
$26.58 M
|
-$19.64 M
|
$6.13 M
|
| Net Income |
$48.58 M
|
$42.42 M
|
$67.44 M
|
-$30.20 M
|
-$12.30 M
|
-$49.28 M
|
-$25.58 M
|
-$29.98 M
|
$64.73 M
|
$11.97 M
|
| Net Income Ratio |
0.12
|
0.12
|
0.21
|
-0.11
|
-0.05
|
-0.2
|
-0.09
|
-0.08
|
0.2
|
0.05
|
| EPS |
0.33 |
0.29 |
0.48 |
-0.27 |
-0.0932 |
-0.46 |
-0.24 |
-0.28 |
0.61 |
0.0037 |
| EPS Diluted |
0.32 |
0.28 |
0.38 |
-0.27 |
-0.0932 |
-0.46 |
-0.24 |
-0.28 |
0.56 |
0.0035 |
| Weighted Average Shares Out |
$147.79 M
|
$146.98 M
|
$116.50 M
|
$112.91 M
|
$110.35 M
|
$108.26 M
|
$106.95 M
|
$105.60 M
|
$106.12 M
|
$105.93 M
|
| Weighted Average Shares Out Diluted |
$149.72 M
|
$149.05 M
|
$145.96 M
|
$112.91 M
|
$110.35 M
|
$108.26 M
|
$106.95 M
|
$105.60 M
|
$116.11 M
|
$112.65 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
